Zevra reports $39.7 million in Q2 2026 revenue, driven by $30.2 million from its NPC-focused therapy Miplyffa. Zevra Therapeutics posted Q2 2026 net revenue of $39.7 million, a 53% year-over-year increase. The growth was led by $30.2 million in sales from Miplyffa, its the
LegalZoom adjusts its revenue outlook as Google’s AI-driven search changes reduce top-of-funnel traffic for the legal services provider. LegalZoom projected 2026 revenue between $795 million and $805 million, citing Google’s accelerated shift to AI-powered search as a key
The firm announces an 11.3% forward yield with dividends payable in October and September for shareholders. Blue Owl Capital declared a $0.31 per share quarterly dividend, offering an 11.3% forward yield. The payout is scheduled for October 15 to shareholders of record as
Hudson Technologies lowers its 2026 gross margin target after the DLA contract reaward impacts profitability expectations. Hudson Technologies revised its 2026 gross margin target to a low-to-mid 20% range following the reaward of a Defense Logistics Agency contract. The a
IonQ posts $80.1 million Q2 revenue IonQ reported its strongest quarter in history with $80.1 million in Q2 2026 revenue. The company's entire quantum platform contributed to this momentum. IonQ's revenue outlook for 2026 is between $280M and $290M followin
The digital advertising firm raised its full-year outlook after exceeding Q2 2026 expectations with robust ex-TAC growth and margins. Magnite revised its full-year 2026 outlook, projecting 13%-14% contribution ex-TAC growth and at least a 37% adjusted EBITDA margin. The up
Investor worries over AI capital expenditure sustainability drove sharp losses in Asian semiconductor shares, triggering a circuit breaker in Korea. Asian tech stocks plunged as concerns over AI-related spending weighed on chipmakers, dragging Japan’s Nikkei down 2% and fo
The outdoor advertising firm increases its payout by 10% to $0.33, yielding 4.11% forward. Outfront Media announced a 10% increase in its quarterly dividend to $0.33 per share, up from $0.30. The new dividend will be payable on September 30 to shareholders of record as of
The biotech firm cites expanding demand and telehealth launches for its raised full-year revenue guidance. Arcutis Biotherapeutics raised its 2026 net revenue guidance to $525M-$540M, up from prior projections. The increase reflects stronger demand for its topical treatmen
The battery maker projects at least $140M in revenue and 28% gross margins for 2026 amid growing SiCore adoption in defense applications. Amprius Technologies (AMPX) announced a 2026 revenue forecast of at least $140M, driven by strong demand for its silicon-anode lithium-
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.